1887

Abstract

The human cytomegalovirus (HCMV) tegument phosphoprotein pp71 activates viral immediate early (IE) transcription and thus has a role in initiating lytic infection. Protein pp71 stimulates expression from a range of promoters in a sequence-independent manner, and in this respect behaves similarly to the herpes simplex virus type 1 (HSV-1) IE protein ICP0. The intracellular localization of pp71 was investigated after its expression from transfected plasmids or from HSV-1 mutants constructed to produce pp71 transiently. The protein colocalized with the cell promyelocytic leukaemia (PML) protein at nuclear domain 10 (ND10) structures but, unlike ICP0, pp71 did not induce disruption of ND10. The activity of pp71 in mouse sensory neurons was investigated after co-inoculation of animals with pairs of HSV-1 mutants, one expressing pp71 and the second containing the . gene controlled by various promoters. In this system, pp71 stimulated β-galactosidase expression from a range of viral IE promoters when mice were analysed at 4 days postinoculation. At later times, expression of pp71 resulted in a reduction in numbers of neurons containing β-galactosidase, indicating cytotoxicity or promoter shutoff. The HSV-1 latency-active promoter was not responsive to pp71, demonstrating specificity in the activity of the protein. Pp71 was as active in mice lacking both copies of the PML gene (PML−/−) as in control animals, and in PML−/− fibroblasts pp71 stimulated gene expression as effectively as in other cell types. Therefore, neither the PML protein nor the normal ND10 structure is necessary for pp71 to stimulate gene expression.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1601
2002-07-01
2024-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831601a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1601&mimeType=html&fmt=ahah

References

  1. Ace C. I., McKee T. A., Ryan J. M., Cameron J. M., Preston C. M. 1989; Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression. Journal of Virology 63:2260–2269
    [Google Scholar]
  2. Ahn J.-H., Hayward G. S. 1997; The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. Journal of Virology 71:4599–4613
    [Google Scholar]
  3. Alvira M. R., Goins W. F., Cohen J. B., Glorioso J. G. 1999; Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. Journal of Virology 73:3866–3876
    [Google Scholar]
  4. Arthur J. L., Everett R. D., Brierly I., Efstathiou S. 1998; Disruption of the 5′ and 3′ splice sites flanking the major latency-associated transcripts of herpes simplex type 1: evidence for alternate splicing in lytic and latent infections. Journal of General Virology 79:107–116
    [Google Scholar]
  5. Baldick C. J., Marchini A., Patterson C. E., Shenk T. 1997; Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. Journal of Virology 71:4400–4408
    [Google Scholar]
  6. Bresnahan W. A., Shenk T. 2000; UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proceedings of the National Academy of Sciences, USA 97:14506–14511
    [Google Scholar]
  7. Chau N. H., Vanson C. D., Kerry J. A. 1999; Transcriptional regulation of the human cytomegalovirus US11 early gene. Journal of Virology 73:863–870
    [Google Scholar]
  8. Dalrymple M. A., McGeoch D. J., Davison A. J., Preston C. M. 1985; DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for the transcriptional activation of immediate early promoters. Nucleic Acids Research 13:7865–7879
    [Google Scholar]
  9. Everett R. D. 1989; Construction and characterisation of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. Journal of General Virology 70:1185–1202
    [Google Scholar]
  10. Everett R. D. 2000a; ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22:761–770
    [Google Scholar]
  11. Everett R. D. 2000b; ICP0 induces the accumulation of colocalizing conjugated ubiquitin. Journal of Virology 74:9994–10005
    [Google Scholar]
  12. Everett R. D., Maul G. G. 1994; HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO Journal 13:5062–5069
    [Google Scholar]
  13. Everett R. D., Freemont P., Saitoh H., Orr A., Kathoria M., Parkinson J. 1998a; The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110 and proteasome-dependent loss of several PML isoforms. Journal of Virology 72:6581–6591
    [Google Scholar]
  14. Everett R. D., Orr A., Preston C. M. 1998b; A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO Journal 17:7161–7169
    [Google Scholar]
  15. Everett R. D., Earnshaw W. C., Findlay J., Lomonte P. 1999; Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO Journal 18:1526–1538
    [Google Scholar]
  16. Farrell M. J., Dobson A. T., Feldman L. T. 1991; Herpes simplex virus latency-associated transcript is a stable intron. Proceedings of the National Academy of Sciences, USA 88:790–794
    [Google Scholar]
  17. Greaves R. F., Mocarski E. S. 1998; Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. Journal of Virology 72:366–379
    [Google Scholar]
  18. Grotziger T., Sternsdorf T., Jensen K., Will H. 1996; Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). European Journal of Biochemistry 238:554–560
    [Google Scholar]
  19. Harris R. A., Preston C. M. 1991; Establishment of latency in vitro by the herpes simplex virus type 1 mutant in 1814. Journal of General Virology 72:907–913
    [Google Scholar]
  20. Hensel G. M., Meyer H. H., Buchman I., Pommerehne D., Schmolke S., Plachter B., Radsak K., Kern H. F. 1996; Intracellular localization and expression of the human cytomegalovirus matrix protein pp71 (UL82): evidence for its translocation to the nucleus. Journal of General Virology 77:3087–3097
    [Google Scholar]
  21. Homer E. G., Rinaldi A., Nicholl M. J., Preston C. M. 1999; Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. Journal of Virology 73:8512–8518
    [Google Scholar]
  22. Hsu W.-L., Everett R. D. 2001; Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex type 1. Journal of Virology 75:3819–3831
    [Google Scholar]
  23. Ishov A. M., Maul G. G. 1996; The periphery of nuclear domain 10 (ND10) as a site of DNA virus deposition. Journal of Cell Science 134:815–826
    [Google Scholar]
  24. Ishov A. M., Stenberg R. M., Maul G. G. 1997; Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. Journal of Cell Biology 138:5–16
    [Google Scholar]
  25. Ishov A. M., Sotnikov A. G., Negorev D., Vladimirova O. V., Neff N., Kamitani T., Yeh E. T. H., Strauss J. F., Maul G. G. 1999; PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. Journal of Cell Biology 147:221–233
    [Google Scholar]
  26. Jamieson D. R. S., Robinson L. H., Daksis J. I., Nicholl M. J., Preston C. M. 1995; Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus Vmw65 mutants. Journal of General Virology 76:1417–1431
    [Google Scholar]
  27. Kelly C., Van Driel R., Wilkinson G. W. G. 1995; Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. Journal of General Virology 76:2887–2893
    [Google Scholar]
  28. Korioth F., Maul G. G., Plachter B., Stamminger T., Frey J. 1996; The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE 1. Experimental Cell Research 229:155–158
    [Google Scholar]
  29. Lachmann R. H., Efstathiou S. 1997; Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. Journal of Virology 71:3197–3207
    [Google Scholar]
  30. Liu B., Stinski M. F. 1992; Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis -acting elements. Journal of Virology 66:4434–4444
    [Google Scholar]
  31. Lokensgard J. R., Berthomme H., Feldman L. T. 1997; The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency. Journal of Virology 71:6714–6719
    [Google Scholar]
  32. Lomonte P., Sullivan K. F., Everett R. D. 2001; Degradation of nucleosome-associated centromeric histone H3-like protein CENP-A induced by herpes simplex virus type 1 protein ICP0. Journal of Biological Chemistry 276:5829–5835
    [Google Scholar]
  33. McFarlane M., Daksis J. I., Preston C. M. 1992; Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65. Journal of General Virology 73:285–292
    [Google Scholar]
  34. Marshall K. R., Lachmann R. H., Efstathiou S., Rinaldi A., Preston C. M. 2000; Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression. Journal of Virology 74:956–964
    [Google Scholar]
  35. Maul G. G. 1998; Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20:660–667
    [Google Scholar]
  36. Maul G. G., Everett R. D. 1994; The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. Journal of General Virology 75:1223–1233
    [Google Scholar]
  37. Maul G. G., Guldner H. H., Spivack J. G. 1993; Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product. Journal of General Virology 74:2679–2690
    [Google Scholar]
  38. Maul G. G., Ishov A., Everett R. D. 1996; Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217:67–75
    [Google Scholar]
  39. Morgenstern J. P., Land H. 1990; A series of mammalian expression vectors and characterization of their expression or a reporter gene in stably and transiently transfected cells. Nucleic Acids Research 18:1068
    [Google Scholar]
  40. Mossman K. L., Smiley J. R. 1999; Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0. Journal of Virology 73:9726–9733
    [Google Scholar]
  41. Nicholl M. J., Preston C. M. 1996; Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific. Journal of Virology 70:6336–6339
    [Google Scholar]
  42. O’Hare P. 1993; The virion transactivator of herpes simplex virus. Seminars in Virology 4:145–155
    [Google Scholar]
  43. Parkinson J., Everett R. D. 2000; Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. Journal of Virology 74:10006–10017
    [Google Scholar]
  44. Preston C. M. 2000; Repression of viral transcription during herpes simplex virus latency. Journal of General Virology 81:1–19
    [Google Scholar]
  45. Preston C. M., McFarlane M. 1998; Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Virology 249:418–426
    [Google Scholar]
  46. Preston C. M., Nicholl M. J. 1997; Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate early protein synthesis. Journal of Virology 71:7807–7813
    [Google Scholar]
  47. Preston C. M., Rinaldi A., Nicholl M. J. 1998; Herpes simplex virus type 1 immediate early gene expression is stimulated by inhibition of protein synthesis. Journal of General Virology 79:117–124
    [Google Scholar]
  48. Rinaldi A., Marshall K. R., Preston C. M. 1999; A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site specific recombination. Virus Research 65:11–20
    [Google Scholar]
  49. Samaniego L. A., Neiderhiser L., DeLuca N. A. 1998; Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. Journal of Virology 72:3307–3320
    [Google Scholar]
  50. Sawtell N. M. 1997; Comprehensive quantification of herpes simplex virus latency at the single-cell level. Journal of Virology 71:5423–5431
    [Google Scholar]
  51. Steiner I., Spivack J. G., Deshmane S. L., Ace C. I., Preston C. M., Fraser N. W. 1990; A herpes simplex virus type 1 mutant containing a non-transinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. Journal of Virology 64:1630–1638
    [Google Scholar]
  52. Stow N. D., Stow E. C. 1986; Isolation and characterisation of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. Journal of General Virology 67:2571–2585
    [Google Scholar]
  53. Stuurman N., de Graaf A., Floore A., Josso A., Humbel B., de Jong L., van Driel R. 1992; A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. Journal of Cell Science 101:773–784
    [Google Scholar]
  54. Tal-Singer R., Pichyangkura R., Chung E., Lasner T. M., Randazzo B. P., Trojanowski J. Q., Fraser N. W., Triezenberg S. J. 1999; The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Virology 259:20–33
    [Google Scholar]
  55. Wang Z. G., Delva L., Gaboli M., Rivi R., Giorgio M., Cordon-Cardo C., Grosveld F., Pandolfi P. P. 1998a; Role of PML in cell growth and the retinoic acid pathway. Science 279:1547–1551
    [Google Scholar]
  56. Wang Z.-G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R., Pandolfi P. P. 1998b; Pml is essential for multiple apoptotic roles. Nature Genetics 20:266–272
    [Google Scholar]
  57. Wilkinson G. W. G., Kelly C., Sinclair J. H., Rickards C. 1998; Disruption of PML-associated nuclear bodies by the human cytomegalovirus major immediate early gene product. Journal of General Virology 79:1233–1245
    [Google Scholar]
  58. Wu N., Watkins S. C., Schaffer P. A., DeLuca N. A. 1996; Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. Journal of Virology 70:6358–6369
    [Google Scholar]
  59. Zhong S., Salomoni P., Ronchetti S., Guo A., Ruggero D., Pandolfi P. P. 2000; Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. Journal of Experimental Medicine 191:631–640
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-83-7-1601
Loading
/content/journal/jgv/10.1099/0022-1317-83-7-1601
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error